Elevance Health Net Worth
Elevance Health Net Worth Breakdown | ELV |
Elevance Health Net Worth Analysis
Elevance Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Elevance Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Elevance Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Elevance Health's net worth analysis. One common approach is to calculate Elevance Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Elevance Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Elevance Health's net worth. This approach calculates the present value of Elevance Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Elevance Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Elevance Health's net worth. This involves comparing Elevance Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Elevance Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Elevance Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elevance Health's net worth research are outlined below:
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 22nd of March 2024 Elevance Health paid $ 1.63 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: U.S. Managed Care Market Report 2024, with Focus on Medicare, Medicaid and Private Health Insurance |
Elevance Health Quarterly Good Will |
|
Elevance Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elevance Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elevance Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 17th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 22nd of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
Elevance Health Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Elevance target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Elevance Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 21 | Strong Buy |
Most Elevance analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Elevance stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Elevance Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationElevance Health Target Price Projection
Elevance Health's current and average target prices are 534.63 and 570.00, respectively. The current price of Elevance Health is the price at which Elevance Health is currently trading. On the other hand, Elevance Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Elevance Health Market Quote on 15th of May 2024
Target Price
Analyst Consensus On Elevance Health Target Price
Know Elevance Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elevance Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elevance Health backward and forwards among themselves. Elevance Health's institutional investor refers to the entity that pools money to purchase Elevance Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Alliancebernstein L.p. | 2023-12-31 | 3.3 M | Baillie Gifford & Co Limited. | 2024-03-31 | 2.9 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.9 M | Nuveen Asset Management, Llc | 2023-12-31 | 2.9 M | Norges Bank | 2023-12-31 | 2.9 M | Northern Trust Corp | 2023-12-31 | 2.3 M | Artisan Partners Limited Partnership | 2023-12-31 | 2.3 M | Jpmorgan Chase & Co | 2023-12-31 | 2.2 M | Legal & General Group Plc | 2023-12-31 | 2.2 M | Vanguard Group Inc | 2023-12-31 | 21.2 M | Blackrock Inc | 2023-12-31 | 21 M |
Follow Elevance Health's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 125.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elevance Health's market, we take the total number of its shares issued and multiply it by Elevance Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Elevance Health's profitablity
Elevance Health's profitability indicators refer to fundamental financial ratios that showcase Elevance Health's ability to generate income relative to its revenue or operating costs. If, let's say, Elevance Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Elevance Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Elevance Health's profitability requires more research than a typical breakdown of Elevance Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.06 | |
| Return On Capital Employed | (0.00006) | (0.000057) | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.15 | 0.1 |
When accessing Elevance Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Elevance Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elevance Health's profitability and make more informed investment decisions.
The data published in Elevance Health's official financial statements usually reflect Elevance Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Elevance Health. For example, before you start analyzing numbers published by Elevance accountants, it's critical to develop an understanding of what Elevance Health's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Elevance Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elevance Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Elevance Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elevance Health. Please utilize our Beneish M Score to check the likelihood of Elevance Health's management manipulating its earnings.
Evaluate Elevance Health's management efficiency
Elevance Health has Return on Asset of 0.0578 % which means that on every $100 spent on assets, it made $0.0578 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1596 %, implying that it generated $0.1596 on every 100 dollars invested. Elevance Health's management efficiency ratios could be used to measure how well Elevance Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2024. Return On Capital Employed is likely to climb to -0.0001 in 2024. At this time, Elevance Health's Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 63 B in 2024, whereas Intangible Assets are likely to drop slightly above 8.3 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 166.62 | 174.95 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 16.17 | 16.98 | |
| Enterprise Value Over EBITDA | 74.57 | 78.30 | |
| Price Book Value Ratio | 2.83 | 1.50 | |
| Enterprise Value Multiple | 74.57 | 78.30 | |
| Price Fair Value | 2.83 | 1.50 | |
| Enterprise Value | 66.6 B | 69.9 B |
The analysis of Elevance Health's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Elevance Health's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Elevance Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 0.7839 | Revenue 171.7 B | Quarterly Revenue Growth 0.01 | Revenue Per Share 731.764 | Return On Equity 0.1596 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevance Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevance Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevance Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Schneider Ryan M. over a month ago Acquisition by Schneider Ryan M. of 457 shares of Elevance Health subject to Rule 16b-3 | ||
Charles Kendrick over a month ago Acquisition by Charles Kendrick of 7786 shares of Elevance Health at 469.03 subject to Rule 16b-3 | ||
Zielinski Thomas C over a year ago Sale by Zielinski Thomas C of 5254 shares of Elevance Health |
Elevance Health Corporate Filings
F4 | 25th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 22nd of April 2024 Other Reports | ViewVerify | |
8K | 18th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 29th of March 2024 Other Reports | ViewVerify |
Elevance Health Earnings Estimation Breakdown
The calculation of Elevance Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Elevance Health is estimated to be 10.01 with the future projection ranging from a low of 9.82 to a high of 10.28. Please be aware that this consensus of annual earnings estimates for Elevance Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
9.82 Lowest | Expected EPS | 10.28 Highest |
Elevance Health Earnings Projection Consensus
Suppose the current estimates of Elevance Health's value are higher than the current market price of the Elevance Health stock. In this case, investors may conclude that Elevance Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Elevance Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2024 | Current EPS (TTM) | |
| 0 | 97.27% | 10.64 | 10.01 | 26.53 |
Elevance Health Earnings per Share Projection vs Actual
Actual Earning per Share of Elevance Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Elevance Health predict the company's earnings will be in the future. The higher the earnings per share of Elevance Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Elevance Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Elevance Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Elevance Health should always be considered in relation to other companies to make a more educated investment decision.Elevance Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Elevance Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-04-18 | 2024-03-31 | 10.53 | 10.64 | 0.11 | 1 | ||
2024-01-24 | 2023-12-31 | 5.64 | 5.62 | -0.02 | 0 | ||
2023-10-18 | 2023-09-30 | 8.44 | 8.99 | 0.55 | 6 | ||
2023-07-19 | 2023-06-30 | 8.8 | 9.04 | 0.24 | 2 | ||
2023-04-19 | 2023-03-31 | 9.26 | 9.46 | 0.2 | 2 | ||
2023-01-25 | 2022-12-31 | 5.19 | 5.23 | 0.04 | 0 | ||
2022-10-19 | 2022-09-30 | 7.15 | 7.53 | 0.38 | 5 | ||
2022-07-20 | 2022-06-30 | 7.74 | 8.04 | 0.3 | 3 | ||
2022-04-20 | 2022-03-31 | 7.81 | 8.25 | 0.44 | 5 | ||
2022-01-26 | 2021-12-31 | 5.11 | 5.14 | 0.03 | 0 | ||
2021-10-20 | 2021-09-30 | 6.37 | 6.79 | 0.42 | 6 | ||
2021-07-21 | 2021-06-30 | 6.33 | 7.03 | 0.7 | 11 | ||
2021-04-21 | 2021-03-31 | 6.51 | 7.01 | 0.5 | 7 | ||
2021-01-27 | 2020-12-31 | 2.52 | 2.54 | 0.02 | 0 | ||
2020-10-28 | 2020-09-30 | 4.15 | 4.2 | 0.05 | 1 | ||
2020-07-29 | 2020-06-30 | 8.87 | 9.2 | 0.33 | 3 | ||
2020-04-29 | 2020-03-31 | 6.48 | 6.48 | 0.0 | 0 | ||
2020-01-29 | 2019-12-31 | 3.88 | 3.88 | 0.0 | 0 | ||
2019-10-23 | 2019-09-30 | 4.82 | 4.87 | 0.05 | 1 | ||
2019-07-24 | 2019-06-30 | 4.61 | 4.64 | 0.03 | 0 | ||
2019-04-24 | 2019-03-31 | 5.81 | 6.03 | 0.22 | 3 | ||
2019-01-30 | 2018-12-31 | 2.2 | 2.44 | 0.24 | 10 | ||
2018-10-31 | 2018-09-30 | 3.7 | 3.81 | 0.11 | 2 | ||
2018-07-25 | 2018-06-30 | 4.16 | 4.25 | 0.09 | 2 | ||
2018-04-25 | 2018-03-31 | 4.88 | 5.41 | 0.53 | 10 | ||
2018-01-31 | 2017-12-31 | 1.27 | 1.29 | 0.02 | 1 | ||
2017-10-25 | 2017-09-30 | 2.42 | 2.65 | 0.23 | 9 | ||
2017-07-26 | 2017-06-30 | 3.23 | 3.37 | 0.14 | 4 | ||
2017-04-26 | 2017-03-31 | 3.86 | 4.68 | 0.82 | 21 | ||
2017-02-01 | 2016-12-31 | 1.61 | 1.76 | 0.15 | 9 | ||
2016-11-02 | 2016-09-30 | 2.47 | 2.45 | -0.02 | 0 | ||
2016-07-27 | 2016-06-30 | 3.23 | 3.33 | 0.1 | 3 | ||
2016-04-27 | 2016-03-31 | 3.32 | 3.46 | 0.14 | 4 | ||
2016-01-27 | 2015-12-31 | 1.2 | 1.14 | -0.06 | 5 | ||
2015-10-28 | 2015-09-30 | 2.33 | 2.73 | 0.4 | 17 | ||
2015-07-29 | 2015-06-30 | 2.77 | 3.1 | 0.33 | 11 | ||
2015-04-29 | 2015-03-31 | 2.67 | 3.14 | 0.47 | 17 | ||
2015-01-28 | 2014-12-31 | 1.72 | 1.73 | 0.01 | 0 | ||
2014-10-29 | 2014-09-30 | 2.27 | 2.36 | 0.09 | 3 | ||
2014-07-30 | 2014-06-30 | 2.26 | 2.44 | 0.18 | 7 | ||
2014-04-30 | 2014-03-31 | 2.12 | 2.3 | 0.18 | 8 | ||
2014-01-29 | 2013-12-31 | 0.87 | 0.87 | 0.0 | 0 | ||
2013-10-23 | 2013-09-30 | 1.82 | 2.1 | 0.28 | 15 | ||
2013-07-24 | 2013-06-30 | 2.11 | 2.6 | 0.49 | 23 | ||
2013-04-24 | 2013-03-31 | 2.38 | 2.94 | 0.56 | 23 | ||
2013-01-23 | 2012-12-31 | 0.95 | 1.03 | 0.08 | 8 | ||
2012-11-07 | 2012-09-30 | 1.84 | 2.09 | 0.25 | 13 | ||
2012-07-25 | 2012-06-30 | 2.08 | 2.04 | -0.04 | 1 | ||
2012-04-25 | 2012-03-31 | 2.27 | 2.34 | 0.07 | 3 | ||
2012-01-25 | 2011-12-31 | 1.12 | 0.99 | -0.13 | 11 | ||
2011-10-26 | 2011-09-30 | 1.68 | 1.77 | 0.09 | 5 | ||
2011-07-27 | 2011-06-30 | 1.8 | 1.83 | 0.03 | 1 | ||
2011-04-27 | 2011-03-31 | 1.87 | 2.35 | 0.48 | 25 | ||
2011-01-26 | 2010-12-31 | 1.23 | 1.33 | 0.1 | 8 | ||
2010-11-03 | 2010-09-30 | 1.58 | 1.74 | 0.16 | 10 | ||
2010-07-28 | 2010-06-30 | 1.55 | 1.67 | 0.12 | 7 | ||
2010-04-28 | 2010-03-31 | 1.67 | 1.95 | 0.28 | 16 | ||
2010-01-27 | 2009-12-31 | 1.02 | 1.16 | 0.14 | 13 | ||
2009-10-28 | 2009-09-30 | 1.37 | 1.78 | 0.41 | 29 | ||
2009-07-29 | 2009-06-30 | 1.43 | 1.5 | 0.07 | 4 | ||
2009-04-22 | 2009-03-31 | 1.25 | 1.62 | 0.37 | 29 | ||
2009-01-28 | 2008-12-31 | 1.36 | 0.65 | -0.71 | 52 | ||
2008-10-22 | 2008-09-30 | 1.49 | 1.6 | 0.11 | 7 | ||
2008-07-23 | 2008-06-30 | 1.36 | 1.44 | 0.08 | 5 | ||
2008-04-23 | 2008-03-31 | 1.19 | 1.07 | -0.12 | 10 | ||
2008-01-23 | 2007-12-31 | 1.51 | 1.51 | 0.0 | 0 | ||
2007-10-24 | 2007-09-30 | 1.44 | 1.45 | 0.01 | 0 | ||
2007-07-25 | 2007-06-30 | 1.35 | 1.35 | 0.0 | 0 | ||
2007-04-25 | 2007-03-31 | 1.26 | 1.26 | 0.0 | 0 | ||
2007-01-24 | 2006-12-31 | 1.27 | 1.27 | 0.0 | 0 | ||
2006-10-25 | 2006-09-30 | 1.23 | 1.24 | 0.01 | 0 | ||
2006-07-26 | 2006-06-30 | 1.14 | 1.18 | 0.04 | 3 | ||
2006-04-26 | 2006-03-31 | 1.07 | 1.1 | 0.03 | 2 | ||
2006-01-25 | 2005-12-31 | 1.04 | 1.05 | 0.01 | 0 | ||
2005-10-26 | 2005-09-30 | 1.01 | 1.02 | 0.01 | 0 | ||
2005-07-27 | 2005-06-30 | 0.97 | 1.0 | 0.03 | 3 | ||
2005-04-27 | 2005-03-31 | 0.91 | 0.94 | 0.03 | 3 | ||
2005-02-07 | 2004-12-31 | 0.84 | 0.85 | 0.01 | 1 | ||
2004-10-27 | 2004-09-30 | 0.83 | 0.84 | 0.01 | 1 | ||
2004-07-27 | 2004-06-30 | 0.82 | 0.83 | 0.01 | 1 | ||
2004-04-28 | 2004-03-31 | 0.73 | 0.81 | 0.08 | 10 | ||
2004-01-29 | 2003-12-31 | 0.69 | 0.72 | 0.03 | 4 | ||
2003-10-27 | 2003-09-30 | 0.66 | 0.68 | 0.02 | 3 | ||
2003-07-31 | 2003-06-30 | 0.62 | 0.65 | 0.03 | 4 | ||
2003-04-30 | 2003-03-31 | 0.59 | 0.59 | 0.0 | 0 | ||
2003-02-02 | 2002-12-31 | 0.55 | 0.56 | 0.01 | 1 | ||
2002-11-04 | 2002-09-30 | 0.5 | 0.53 | 0.03 | 6 | ||
2002-08-05 | 2002-06-30 | 0.49 | 0.5 | 0.01 | 2 | ||
2002-04-29 | 2002-03-31 | 0.42 | 0.47 | 0.05 | 11 | ||
2002-02-06 | 2001-12-31 | 0.45 | 0.48 | 0.03 | 6 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elevance Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Elevance Health Corporate Management
Elected by the shareholders, the Elevance Health's board of directors comprises two types of representatives: Elevance Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevance. The board's role is to monitor Elevance Health's management team and ensure that shareholders' interests are well served. Elevance Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevance Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Rigg | SVP Division | Profile | |
| Ronald Penczek | Controller VP | Profile | |
| Scott Anglin | Treasurer SVP | Profile | |
| John Gallina | Ex CFO | Profile | |
| Julie Goon | Senior Affairs | Profile | |
| Felicia Norwood | Executive Benefits | Profile | |
| Charles Kendrick | Executive Benefits | Profile |
How to buy Elevance Stock?
The net worth of Elevance Health is the difference between its total assets and liabilities. Elevance Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Elevance Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Elevance Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if Elevance Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Elevance Health stock.Already Invested in Elevance Health?
The danger of trading Elevance Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Elevance Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Elevance Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Elevance Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Elevance Health is a strong investment it is important to analyze Elevance Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Elevance Health's future performance. For an informed investment choice regarding Elevance Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevance Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Elevance Stock analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Elevance Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevance Health. If investors know Elevance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevance Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.155 | Dividend Share 6.07 | Earnings Share 26.53 | Revenue Per Share 731.764 | Quarterly Revenue Growth 0.01 |
The market value of Elevance Health is measured differently than its book value, which is the value of Elevance that is recorded on the company's balance sheet. Investors also form their own opinion of Elevance Health's value that differs from its market value or its book value, called intrinsic value, which is Elevance Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevance Health's market value can be influenced by many factors that don't directly affect Elevance Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevance Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevance Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevance Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.